Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

BACKGROUND: Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanet, Delia, Egan, Aoife, Fhelelboom, Narjes, Biesty, Linda, Thangaratinam, Shakila, Dempsey, Eugene, Crowther, Caroline, Devane, Declan, Dunne, Fidelma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321696/
https://www.ncbi.nlm.nih.gov/pubmed/30611300
http://dx.doi.org/10.1186/s13063-018-3059-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321696/
https://www.ncbi.nlm.nih.gov/pubmed/30611300
http://dx.doi.org/10.1186/s13063-018-3059-8

Ejemplares similares